Stock overview
Kymera Therapeutics, Inc.
Explore the company, reported ownership, price history, and available source evidence.
KYMERA THERAPEUTICS, INC. (KYMR) is a listed warrant, unit, right, or acquisition-company security tracked from 13F filings.
- Last close
- $111.95
- · KYMR
- Tracked holders
- 2 funds
- Latest available 13F per fund
KYMR · USD
Price
$111.95
+$58.21
(+108.34%)
over selected range
Close · Sep 25, 2026
Market open
252 stored daily closes
$111.95
Sep 25, 2026
- Range low
- $53.74
- Range high
- $127.31
- Observations
- 252
- Session date
- Sep 25, 2026
Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $992,725,940 | 4.97% |
| Bessemer Venture Partners position history Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $14,436,380 | 1.78% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market